The DOI matches its Crossref record; 256 of the 256 references it cites were found in a registry or an index.
G Protein-Coupled Receptor Allosterism and Complexing
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Items 201–256 of 256
Agonist-specific receptor conformations
Kenakin, T. P. (1997) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(97)01127-9 · Cited by 88
Self-citationMassot, O., Rousselle, J. C., Fillion, M. P., Grimaldi, B., Cloëz-Tayarani, I., Fugelli, A., Prudhomme, N., Seguin, L., Rousseau, B., Plantefol, M., et al. (1996) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09375-7 · Cited by 88
Cys-140 Is Critical for Metabotropic Glutamate Receptor-1 Dimerization
Ray, K., & Hauschild, B. C. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m005581200 · Cited by 86
Wess, J. (1993) · Life Sciences · doi:10.1016/0024-3205(93)90618-d · Cited by 85
Coleman, R. A., Johnson, M. W., Niais, A. T., et al. (1996) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(96)10040-7 · Cited by 83
Fawzi, A. B., Macdonald, D., Benbow, L. L., Smith-Torhan, A., Zhang, H., Weig, B. C., Ho, G., Tulshian, D., Linder, M. E., & Graziano, M. P. (2001) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)12353-x · Cited by 82
On the Application of R-Curves and Maximum Load Toughness to Structures
Anderson, T., Gordon, J. R., & Garwood, S. J. (1988) · doi:10.1520/stp33080s · Cited by 82
The turning wheel: a study in steady states.
Wyman, J. (1975) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.72.10.3983 · Cited by 82
Popova, J. S., Johnson, G. L., & Rasenick, M. M. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)31868-9 · Cited by 80
Lüllmann, H., Ohnesorge, F. K., Schauwecker, G.-C., & Wassermann, O. (1969) · European Journal of Pharmacology · doi:10.1016/0014-2999(69)90181-2 · Cited by 79
Gao, Z., van Muijlwijk‐Koezen, J. E., Chen, A., Müller, C. E., IJzerman, A. P., & Jacobson, K. A. (2001) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)12515-1 · Cited by 78
GAP-43 augments G protein-coupled receptor transduction in Xenopus laevis oocytes.
Strittmatter, S. M., Cannon, S. C., Ross, E. M., Higashijima, T., & Fishman, M. C. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.11.5327 · Cited by 75
Howard, O. M. Z., Oppenheim, J. J., Hollingshead, M. G., Covey, J. M., Bigelow, J. C., McCormack, J. J., Robert W. Buckheit, Clanton, D. J., Turpin, J. A., & Rice, W. G. (1998) · Journal of Medicinal Chemistry · doi:10.1021/jm9801253 · Cited by 72
Biochemical and biophysical demonstration of GPCR oligomerization in mammalian cells
Angers, S., Salahpour, A., & Bouvier, M. (2001) · Life Sciences · doi:10.1016/s0024-3205(01)01012-8 · Cited by 72
Ikezu, T., Okamoto, T., Ogata, E., & Nishimoto, I. (1992) · FEBS Letters · doi:10.1016/0014-5793(92)81359-t · Cited by 69
Howard, O. M. Z., Shirakawa, A., Turpin, J. A., Maynard, A. T., Tobin, G. J., Carrington, M. N., Oppenheim, J. J., & Dean, M. C. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.23.16228 · Cited by 69
Wade, S. M., Lim, W. K., Lan, K.-L., et al. (1999) · Molecular Pharmacology · doi:10.1124/mol.56.5.1005 · Cited by 68
Factors Determining Specificity of Signal Transduction by G-protein-coupled Receptors
Sato, M., Kataoka, R., Dingus, J., Wilcox, M. D., Hildebrandt, J. D., & Lanier, S. M. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.25.15269 · Cited by 68
Huang, R. R., DeHaven, R. N., Cheung, A. H., Diehl, R. E., Dixon, R. A., & Strader, C. D. (1990) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09974-2 · Cited by 68
Allosteric modulators of ligand binding to muscarinic acetylcholine receptors
Holzgrabe, U., & Mohr, K. (1998) · Drug Discovery Today · doi:10.1016/s1359-6446(97)01161-6 · Cited by 67
Inhibition of Lysosomal Plasminogen Activator Activity in Experimental Shock
Tauber, P. F. (2008) · Pharmacology · doi:10.1159/000136361 · Cited by 66
Leuthäuser, K., Gujer, R., Aldecoa, A., McKinney, R. A., Muff, R., Fischer, J. A., & Born, W. (2000) · Biochemical Journal · doi:10.1042/bj3510347 · Cited by 66
Spedding, M., Sweetman, A. J., & Weetman, D. F. (1975) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1975.tb07397.x · Cited by 65
The Stability of the Agonist β2-Adrenergic Receptor-Gs Complex: Evidence for Agonist-Specific States
Krumins, A. M., & Barber, R. (1997) · Molecular Pharmacology · doi:10.1124/mol.52.1.144 · Cited by 64
Allosteric regulation by oleamide of the binding properties of 5-hydroxytryptamine7 receptors
Hedlund, P. B., Carson, M. J., Sutcliffe, J. G., & Thomas, E. A. (1999) · Biochemical Pharmacology · doi:10.1016/s0006-2952(99)00274-9 · Cited by 60
Butler, S. J., Kelly, E. C. H., McKenzie, F. R., Guild, S., Wakelam, M. J. O., & Milligan, G. (1988) · Biochemical Journal · doi:10.1042/bj2510201 · Cited by 59
Assessment of ternary model for the binding of agonists to neurohumoral receptors
Lee, T. W. T., Sole, M. J., & Wells, J. W. (1986) · Biochemistry · doi:10.1021/bi00370a038 · Cited by 57
Buller, S., Zlotos, D. P., Mohr, K., & Ellis, J. (2002) · Molecular Pharmacology · doi:10.1124/mol.61.1.160 · Cited by 56
Qualitative and quantitative assessment of relative agonist efficacy
Christopoulos, A., & El‐Fakahany, E. E. (1999) · Biochemical Pharmacology · doi:10.1016/s0006-2952(99)00087-8 · Cited by 54
Self-citationOnaran, H., Scheer, A., Cotecchia, S., & Costa, T. (2000) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-57081-0_9 · Cited by 54
Negative Cooperativity in the Human Bradykinin B2Receptor
Pizard, A., Marchetti, J., Allegrini, J., Alhenc‐Gelas, F., & Rajerison, R. M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.3.1309 · Cited by 53
Kourounakis, A. P., Visser, C. C., de Groote, M., & IJzerman, A. P. (2001) · Biochemical Pharmacology · doi:10.1016/s0006-2952(00)00536-0 · Cited by 49
Ellis, J. E., & Seidenberg, M. (2000) · Molecular Pharmacology · doi:10.1124/mol.58.6.1451 · Cited by 49
Overview of Receptor Allosterism
Gregory, K. J., Sexton, P. M., & Christopoulos, A. (2010) · Current Protocols in Pharmacology · doi:10.1002/0471141755.ph0121s51 · Cited by 48
Self-citationCharacterization of a G-protein Activator in the Neuroblastoma-Glioma Cell Hybrid NG108-15
Sato, M., Ribas, C., Hildebrandt, J. D., & Lanier, S. M. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.47.30052 · Cited by 47
Small molecule inhibitor of HIV-1 cell fusion blocks chemokine receptor-mediated function
Howard, O. M. Z., Korte, T., Tarasova, N. I., Grimm, M., Turpin, J. A., Rice, W. G., Michejda, C. J., Blumenthal, R. P., & Oppenheim, J. J. (1998) · Journal of Leukocyte Biology · doi:10.1002/jlb.64.1.6 · Cited by 47
Signal transduction by calcitonin
Horne, W. C., Shyu, J., Chakraborty, M., & Baron, R. (1994) · Trends in Endocrinology and Metabolism · doi:10.1016/1043-2760(95)92521-j · Cited by 44
Kenakin, T., & Boselli, C. (1989) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)22846-4 · Cited by 42
Self-citationAdenosine A1 Receptor-Dependent and -Independent Effects of the Allosteric Enhancer PD 81,723
Musser, B., Mudumbi, R. V., Liu, J., Olson, R. D., & Vestal, R. E. (1999) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37975-3 · Cited by 40
Leach, K., Sexton, P. M., & Christopoulos, A. (2011) · Current Protocols in Pharmacology · doi:10.1002/0471141755.ph0122s52 · Cited by 39
Self-citationCo-agonism in drug-receptor interaction: illustrated by the NMDA receptors
Corsi, M., Fina, P., & Trist, D. G. (1996) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(96)10018-3 · Cited by 39
Leppik, R. A., Mynett, A., Lazareno, S., & Birdsall, N. J. M. (2000) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)26407-5 · Cited by 38
Multiple allosteric sites on muscarinic receptors
Nj, B., Lazareno, S., Popham, A., & Saldanha, J. W. (2001) · Life Sciences · doi:10.1016/s0024-3205(01)01047-5 · Cited by 38
Cloëz-Tayarani, I., Cardona, A., Rousselle, J.-C., Massot, O., Edelman, L., & Fillion, G. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.18.9899 · Cited by 38
Aspirin and Sodium Salicylate Inhibit Endothelin ETA Receptors by an Allosteric Type of Mechanism
Talbodec, A., Berkane, N., Blandin, V., Breittmayer, J. P., Ferrari, É., Frelin, C., & Vigne, P. (2000) · Molecular Pharmacology · doi:10.1124/mol.57.4.797 · Cited by 34
Receptor crosstalk protein, calcyon, regulates affinity state of dopamine D1 receptors
Lidow, M. S., Roberts, A., Zhang, L., et al. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)01265-1 · Cited by 32
SK‐N‐BE: A Human Neuroblastoma Cell Line Containing Two Subtypes of δ‐Opioid Receptors
Polastron, J., Mur, M., Mazarguil, H., Puget, A., Meunier, J., & Jauzac, P. (1994) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1994.62030898.x · Cited by 32
Dominant‐negative activity of an α1B‐adrenergic receptor signal‐inactivating point mutation
Chen, S., Lin, F., Xu, M., et al. (2000) · The EMBO Journal · doi:10.1093/emboj/19.16.4265 · Cited by 32
Lanzafame, A., Christopoulos, A., & Mitchelson, F. J. (1997) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36766-7 · Cited by 32
Self-citationMeller, E., Puza, T., Diamond, J., et al. (1992) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)10372-8 · Cited by 31
Allosteric Interactions of Muscarinic Receptors and Their Regulation by Other Membrane Proteins
Henis, Y. I., Kloog, Y., & Sokolovsky, M. (1989) · Humana Press eBooks · doi:10.1007/978-1-4612-4498-1_10 · Cited by 22
Allosteric Inhibition of Endothelin ETA Receptors by 3,5-Dibromosalicylic Acid
Blandin, V., Vigne, P., Breittmayer, J. P., & Frelin, C. (2000) · Molecular Pharmacology · doi:10.1124/mol.58.6.1461 · Cited by 21
Seifert, R., Gether, U., Wenzel‐Seifert, K., et al. (1999) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)12645-4 · Cited by 21
Specificity of Receptor–G Protein Coupling: Protein Structure and Cellular Determinants
Neubig, R. R. (1998) · Seminars in Neuroscience · doi:10.1006/smns.1997.0117 · Cited by 19
Quantitation of allosteric interaction
Lazareno, S., & Birdsall, N. J. M. (1996) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(97)88187-4 · Cited by 9
Proteins-Paradigms of complex systems
Frauenfelder, H. (1995) · Cellular and Molecular Life Sciences · doi:10.1007/bf01931093 · Cited by 8
Cited by
Functional Selectivity and Classical Concepts of Quantitative Pharmacology
Urban, J. D., Clarke, W. P., von Zastrow, M., Nichols, D. E., Kobilka, B., Weinstein, H., Javitch, J. A., Roth, B. L., Christopoulos, A., Sexton, P. M., et al. (2007) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.104463 · Cited by 1,116
Self-citationAllosteric modulators of GPCRs: a novel approach for the treatment of CNS disorders
Jeffrey Conn, P., Christopoulos, A., & Lindsley, C. W. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2760 · Cited by 1,063
Self-citationCannabidiol is a negative allosteric modulator of the cannabinoid CB 1 receptor
Laprairie, R. B., Bagher, A. M., Kelly, M. E. M., & Denovan‐Wright, E. M. (2015) · British Journal of Pharmacology · doi:10.1111/bph.13250 · Cited by 1,039
Small molecule modulation of Smoothened activity
Chen, J. K., Taipale, J., Young, K. E., Maiti, T., & Beachy, P. A. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.182542899 · Cited by 992
Allosteric Modulation of G Protein–Coupled Receptors
May, L. T., Leach, K., Sexton, P. M., & Christopoulos, A. (2007) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.47.120505.105159 · Cited by 695
Self-citation
Metadata
- Authors
- Christopoulos, A., & Kenakin, T.
- Venue
- Pharmacological Reviews
- Publisher
- Elsevier BV
- Published
- 2002-06
- Volume
- 54
- Issue
- 2
- Pages
- 323-374
- ISSN
- 0031-6997 (ISSN-L)
- OpenAlex
- W2095775529
- Cited by
- 931
- References
- 256
- FWCI
- 15.12
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.